SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon sells 1.88% stake in Syngene for around Rs 230 crore

18 May 2018 Evaluate

Biocon, the Promoter of Syngene International, on May 16, 2018 has sold 37,65,574 Equity Shares amounting to 1.88% of the Equity Share capital of Syngene International through open market sale.

Based on average weighted price of Syngene's shares on May 16 at Rs 611.02 apiece, the transaction is estimated at Rs 230.08 crore. 

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Biocon Share Price

427.05 8.15 (1.95%)
03-Jul-2026 12:53 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1910.75
Dr. Reddys Labs. 1385.90
Cipla 1463.65
Zydus Lifesciences 1133.00
Lupin 2470.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: